Physician profile
Umar Farooq
NPI 1295775534
$10,419.26
in general payments reported to CMS, 2019-2025
57 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $878 · 2021: $1,792 · 2022: $1,294 · 2023: $1,946 · 2024: $2,275 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,633 · Education: $52.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,633.31 |
| Education | $52.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,592.27 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,296.47 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $751.61 | 2019-2025 | |
| Abbvie INC. | $599.89 | 2021-2025 | |
| Amgen INC. | $494.87 | 2019-2025 | Repatha, Otezla, Otezla |
| Intuity Medical INC | $409.51 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Merck Sharp & Dohme LLC | $395.12 | 2019-2025 | Belsomra, Steglatro, Capvaxive |
| Otsuka America Pharmaceutical, INC. | $381.36 | 2023-2025 | Rexulti, Nuedexta |
| Lilly USA, LLC | $368.37 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $357.94 | 2019-2025 | Jardiance |
| Corcept Therapeutics | $347.86 | 2023-2025 | Korlym |
| Exact Sciences Corporation | $300.71 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $300.14 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $292.62 | 2022 | |
| Ucb, INC. | $269.07 | 2020-2025 | Nayzilam |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $266.36 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $170.48 | 2019-2023 | |
| Abbott Laboratories | $167.80 | 2021-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $131.29 | 2019-2022 | |
| Lundbeck LLC | $121.28 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.76 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $106.87 | 2022-2025 | Gvoke Hypopen, Recorlev |
| E.R. Squibb & Sons, L.L.C. | $81.98 | 2019-2021 | |
| Allergan, INC. | $79.94 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.40 | 2022-2024 | |
| Biogen, INC. | $76.12 | 2021-2024 | Skyclarys |
| Glaxosmithkline, LLC. | $69.10 | 2020-2023 | Shingrix, Arexvy |
| Avanir Pharmaceuticals, INC. | $66.88 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $48.03 | 2021 | |
| Radius Health, INC. | $47.88 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $44.83 | 2020-2021 | |
| Inspire Medical Systems, INC. | $41.72 | 2024-2025 | Inspire |
| Eisai INC. | $35.48 | 2021 | |
| Astellas Pharma US INC | $35.36 | 2022-2023 | Veozah |
| Dexcom, INC. | $33.32 | 2021-2024 | Dexcom G6 Transmitter |
| Althera Pharmaceuticals LLC | $33.20 | 2021 | |
| Pulmonx Corporation | $32.26 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Boston Scientific Corporation | $32.11 | 2024 | Latitude Communicator Power Supply |
| Intra-Sana Laboratories | $30.89 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Alexion Pharmaceuticals, INC. | $26.82 | 2024 | Soliris |
| Penumbra, INC. | $24.83 | 2023 | Indigo System |
| Sanofi Pasteur INC. | $23.19 | 2023 | |
| Phathom Pharmaceuticals, INC. | $20.71 | 2025 | Voquezna |
| Urovant Sciences INC | $20.32 | 2022 | |
| Abiomed | $19.65 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $19.29 | 2023 | Crysvita |
| Chiesi USA, INC. | $17.71 | 2025 | Cleviprex, Kengreal |
| Arbor Pharmaceuticals, INC. | $16.35 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $15.86 | 2021 | |
| Esperion Therapeutics, INC. | $15.48 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.86 | 2019 | |
| Neurelis, INC. | $13.97 | 2023 | Valtoco |
| Seqirus USA INC | $13.88 | 2019 | |
| Linus Health, INC. | $13.51 | 2023 | |
| Shield Therapeutics INC | $12.65 | 2022 | |
| Horizon Therapeutics Plc | $12.63 | 2020 | |
| Theracosbio, LLC | $11.40 | 2024 | Brenzavvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.